持続血糖モニタリング (CGM) の世界市場 (2022年-2027年)：市場規模・予測・産業動向・シェア・成長率・インサイト・COVID-19の影響・企業分析

世界の持続血糖モニタリング (CGM) の市場規模は2021年から2027年にかけてCAGR 6.60％で推移し、2027年には84億8,000万米ドルの規模に成長すると予測されています。

高齢者人口の急増や、糖尿病の有病率の増加が同市場を拡大させる重要な要因となっています。糖尿病患者の増加に伴い、多くの参入事業者による革新的な製品や製品ラインの開発が促進され、市場成長が見込まれています。

当レポートでは、世界の持続血糖モニタリング (CGM) の市場を調査し、市場概要、市場成長への影響因子の分析、市場規模 (金額・数量) の推移・予測、主要国別の詳細分析、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

• 促進要因
• 課題

第5章 世界の持続血糖モニタリング (CGM) 市場・ユーザー分析

• 市場
• ユーザー

第6章 世界の持続血糖モニタリング (CGM) 市場：コンポーネント別

• 血糖センサー市場
• CGMトランスミッター市場

第7章 世界の持続血糖モニタリング (CGM) 市場・CGMユーザーシェア分析

• CGM市場シェア
• CGMユーザーシェア

第8章 世界のCGM (持続血糖モニタリング) 償還モデル

第9章 Abbott Freestyle LibreとCGM (持続血糖モニタリング)

第10章 米国

• 糖尿病人口
• 市場規模
• ユーザー数
• 償還

第11章 カナダ

• 糖尿病人口
• 市場規模
• ユーザー数
• 償還

第12章 ドイツ

• 糖尿病人口
• 市場規模
• ユーザー数
• 償還

第13章 オーストラリア

• 糖尿病人口
• 市場規模
• ユーザー数
• 償還

第14章 フランス

• 糖尿病人口
• 市場規模
• ユーザー数
• 償還

第15章 オランダ

• 糖尿病人口
• 市場規模
• ユーザー数
• 償還

第16章 スイス

• 糖尿病人口
• 市場規模
• ユーザー数
• 償還

第17章 スウェーデン

• 糖尿病人口
• 市場規模
• ユーザー数
• 償還

第18章 イスラエル

• 糖尿病人口
• 市場規模
• ユーザー数
• 償還

第19章 英国

• 糖尿病人口
• 市場規模
• ユーザー数
• 償還

第20章 日本

第21章 企業分析

• Abbott Laboratories
• Roche
• Tandem Diabetes Care
• Dexcom Inc
• Senseonics

List of Figures

• Figure-01: Global - Continuous Glucose Monitoring Market (Million US$), 2017 - 2021
• Figure-02: Global - Forecast for Continuous Glucose Monitoring Market (Million US$), 2022 - 2027
• Figure-03: Global - Continuous Glucose Monitoring User Volume (Thousand), 2017 - 2021
• Figure-04: Global - Forecast for Continuous Glucose Monitoring User Volume (Thousand), 2022 - 2027
• Figure-05: Global - Glucose Sensor Market (Million US$), 2017 - 2021
• Figure-06: Global - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
• Figure-07: Global - CGM Transmitter Market (Million US$), 2017 - 2021
• Figure-08: Global - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
• Figure-09: United States - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
• Figure-10: United States - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
• Figure-11: United States - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
• Figure-12: United States - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
• Figure-13: United States - Glucose Sensor Market (Million US$), 2017 - 2021
• Figure-14: United States - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
• Figure-15: United States - CGM Transmitter Market (Million US$), 2017 - 2021
• Figure-16: United States - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
• Figure-17: United States - CGM User Volume (Number), 2017 - 2021
• Figure-18: United States - Forecast for CGM User Volume (Number), 2022 - 2027
• Figure-19: Canada - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
• Figure-20: Canada - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
• Figure-21: Canada - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
• Figure-22: Canada - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
• Figure-23: Canada - Glucose Sensor Market (Million US$), 2017 - 2021
• Figure-24: Canada - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
• Figure-25: Canada - CGM Transmitter Market (Million US$), 2017 - 2021
• Figure-26: Canada - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
• Figure-27: Canada - CGM User Volume (Number), 2017 - 2021
• Figure-28: Canada - Forecast for CGM User Volume (Number), 2022 - 2027
• Figure-29: Germany - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
• Figure-30: Germany - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
• Figure-31: Germany - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
• Figure-32: Germany - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
• Figure-33: Germany - Glucose Sensor Market (Million US$), 2017 - 2021
• Figure-34: Germany - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
• Figure-35: Germany - CGM Transmitter Market (Million US$), 2017 - 2021
• Figure-36: Germany - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
• Figure-37: Germany - CGM User Volume (Number), 2017 - 2021
• Figure-38: Germany - Forecast for CGM User Volume (Number), 2022 - 2027
• Figure-39: Australia - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
• Figure-40: Australia - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
• Figure-41: Australia - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
• Figure-42: Australia - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
• Figure-43: Australia - Glucose Sensor Market (Million US$), 2017 - 2021
• Figure-44: Australia - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
• Figure-45: Australia - CGM Transmitter Market (Million US$), 2017 - 2021
• Figure-46: Australia - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
• Figure-47: Australia - CGM User Volume (Number), 2017 - 2021
• Figure-48: Australia - Forecast for CGM User Volume (Number), 2022 - 2027
• Figure-49: France - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
• Figure-50: France - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
• Figure-51: France - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
• Figure-52: France - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
• Figure-53: France - Glucose Sensor Market (Million US$), 2017 - 2021
• Figure-54: France - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
• Figure-55: France - CGM Transmitter Market (Million US$), 2017 - 2021
• Figure-57: France - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
• Figure-56: France - CGM User Volume (Number), 2017 - 2021
• Figure-58: France - Forecast for CGM User Volume (Number), 2022 - 2027
• Figure-59: Netherlands - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
• Figure-60: Netherlands - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
• Figure-61: Netherlands - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
• Figure-62: Netherlands - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
• Figure-63: Netherlands - Glucose Sensor Market (Million US$), 2017 - 2021
• Figure-64: Netherlands - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
• Figure-65: Netherlands - CGM Transmitter Market (Million US$), 2017 - 2021
• Figure-66: Netherlands - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
• Figure-67: Netherlands - CGM User Volume (Number), 2017 - 2021
• Figure-68: Netherlands - Forecast for CGM User Volume (Number), 2022 - 2027
• Figure-69: Switzerland - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
• Figure-70: Switzerland - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
• Figure-71: Switzerland - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
• Figure-72: Switzerland - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
• Figure-73: Switzerland - Glucose Sensor Market (Million US$), 2017 - 2021
• Figure-74: Switzerland - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
• Figure-75: Switzerland - CGM Transmitter Market (Million US$), 2017 - 2021
• Figure-76: Switzerland - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
• Figure-77: Switzerland - CGM User Volume (Number), 2017 - 2021
• Figure-78: Switzerland - Forecast for CGM User Volume (Number), 2022 - 2027
• Figure-79: Sweden - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
• Figure-80: Sweden - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
• Figure-81: Sweden - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
• Figure-82: Sweden - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
• Figure-83: Sweden - Glucose Sensor Market (Million US$), 2017 - 2021
• Figure-84: Sweden - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
• Figure-85: Sweden - CGM Transmitter Market (Million US$), 2017 - 2021
• Figure-86: Sweden - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
• Figure-87: Sweden - CGM User Volume (Number), 2017 - 2021
• Figure-88: Sweden - Forecast for CGM User Volume (Number), 2022 - 2027
• Figure-89: Israel - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
• Figure-90: Israel - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
• Figure-91: Israel - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
• Figure-92: Israel - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
• Figure-93: Israel - Glucose Sensor Market (Million US$), 2017 - 2021
• Figure-94: Israel - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
• Figure-95: Israel - CGM Transmitter Market (Million US$), 2017 - 2021
• Figure-96: Israel - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
• Figure-97: Israel - CGM User Volume (Number), 2017 - 2021
• Figure-98: Israel - Forecast for CGM User Volume (Number), 2022 - 2027
• Figure-99: United Kingdom - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
• Figure-100: United Kingdom - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
• Figure-101: United Kingdom - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
• Figure-102: United Kingdom - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
• Figure-103: United Kingdom - Glucose Sensor Market (Million US$), 2017 - 2021
• Figure-104: United Kingdom - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
• Figure-105: United Kingdom - CGM Transmitter Market (Million US$), 2017 - 2021
• Figure-106: United Kingdom - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
• Figure-107: United Kingdom - CGM User Volume (Number), 2017 - 2021
• Figure-108: United Kingdom - Forecast for CGM User Volume (Number), 2022 - 2027
• Figure-109: Japan - Diabetes Population Type 1 Volume (Thousand), 2017 - 2021
• Figure-110: Japan - Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 - 2027
• Figure-111: Japan - Diabetes Population Type 2 Volume (Thousand), 2017 - 2021
• Figure-112: Japan - Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 - 2027
• Figure-113: Japan - Glucose Sensor Market (Million US$), 2017 - 2021
• Figure-114: Japan - Forecast for Glucose Sensor Market (Million US$), 2022 - 2027
• Figure-115: Japan - CGM Transmitter Market (Million US$), 2017 - 2021
• Figure-116: Japan - Forecast for CGM Transmitter Market (Million US$), 2022 - 2027
• Figure-117: Japan - CGM User Volume (Number), 2017 - 2021
• Figure-118: Japan - Forecast for CGM User Volume (Number), 2022 - 2027
• Figure-119: Abbott Laboratories - Global Revenue (Million US$), 2017 - 2021
• Figure-120: Abbott Laboratories - Forecast for Global Revenue (Million US$), 2022 - 2027
• Figure-121: Roche - Global Revenue (Million US$), 2017 - 2021
• Figure-122: Roche - Forecast for Global Revenue (Million US$), 2022 - 2027
• Figure-123: Tandem Diabetes Care - Global Revenue (Million US$), 2017 - 2021
• Figure-124: Tandem Diabetes Care - Forecast for Global Revenue (Million US$), 2022 - 2027
• Figure-125: Dexcom Inc - Global Revenue (Million US$), 2017 - 2021
• Figure-126: Dexcom Inc - Forecast for Global Revenue (Million US$), 2022 - 2027
• Figure-127: Senseonics - Global Revenue (Million US$), 2017 - 2021
• Figure-128: Senseonics - Forecast for Global Revenue (Million US$), 2022 - 2027

List of Tables

• Table-01: Global - CGM Market Share by Countries (Percent), 2017 - 2021
• Table-02: Global - Forecast for CGM Market Share by Countries (Percent), 2022 - 2027
• Table-03: Global - Glucose Sensor Market Share by Countries (Percent), 2017 - 2021
• Table-04: Global - Forecast for Glucose Sensor Market Share by Countries (Percent), 2022 - 2027
• Table-05: Global - CGM Transmitter Market Share by Countries (Percent), 2017 - 2021
• Table-06: Global - Forecast for CGM Transmitter Market Share by Countries (Percent), 2022 - 2027
• Table-07: Global - CGM User Volume Share by Countries (Percent), 2017 - 2021
• Table-08: Global - Forecast for CGM User Volume Share by Countries (Percent), 2022 - 2027

According to Renub Research, Continuous Glucose Monitoring Market is estimated to reach US$ 8.48 Billion by 2027. One of the most recent technical evolutions in diabetes management is continuous glucose monitoring (CGM). In brief, a CGM system is a form of glucose monitoring device that works by inserting a biosensor either transcutaneously or subcutaneously. Furthermore, the embedded sensor detects glucose levels in interstitial fluid or blood. It communicates the data to a receiver/monitor for display. Due to their numerous advantages over traditional glucose monitoring devices, these systems play an essential role in diabetes care. Unlike traditional glucose monitors, these devices allow for continuous glucose monitoring, which is critical for avoiding diabetic complications.

Global Continuous Glucose Monitoring Market Size Is Expanding with a CAGR Of 6.60% During 2021-2027:

The spike in the geriatric population and the increasing prevalence of diabetes have been essential factors driving the CGM market's expansion over the years worldwide. Furthermore, as the number of diabetic cases rises, the market for continuous glucose monitoring systems is predicted to grow and expand, attracting and compelling many industry participants to develop innovative products or product line extensions. Moreover, substantial growth potential in undeveloped areas is expected to generate significant profit opportunities for manufacturers during the anticipated period. However, a lack of proper funding for devices is a substantial impediment to their widespread adoption.

COVID-19 Impact on Continuous Glucose Monitoring Industry:

According to the World Health Organization (WHO), the number of people with type 2 diabetes has been rising in most nations, according to the World Health Organization (WHO). Furthermore, according to our findings, the COVID-19 epidemic has increased the necessity of evaluating the feasibility of continuous glucose monitoring (CGM) in hospitals to preserve personal protective equipment (PPE) and restrict exposure to health care workers. As a result, the Continuous Glucose Monitoring Market has grown even during the epidemic. Moreover, as per our analysis, Global Continuous Glucose Monitoring Market reached US$. 5.78 Billion in 2021.

Segment Analysis in Continuous Glucose Monitoring Market:

The Global Continuous Glucose Monitoring Market is studied in the United States, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, United Kingdom, and Japan. Further, the market in detail is categorized based on Diabetes Population (Type 1 and Type 2, CGM Market, CGM Market by Components, Glucose Sensor Market, CGM Transmitter Market, CGM User, and CGM Reimbursement.

Competitive Landscape:

The Continuous Glucose Monitoring (CGM) Market is highly competitive, with only a few companies competing. Abbott Laboratories, Roche, Tandem Diabetes Care, Dexcom Inc, and Senseonics are among the important players profiled in our analysis. These firms control a significant portion of the global market. In addition, they are continually entering new markets to develop new revenue streams and strengthen existing ones. These market actors' actions will create a competitive marketplace, forcing enterprises to experiment with the latest technology to maintain originality in their products. Companies are also working together to improve their technical knowledge and shorten the product development cycle.

Renub Research latest report "Continuous Glucose Monitoring (CGM) Market, Global Forecast, By Components (Glucose Sensor Market and CGM Transmitter Market), Countries (United States, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, United Kingdom and Japan), Country Insights (Diabetes Population (Type 1 and Type 2), CGM Market, CGM Market by Components, Glucose Sensor Market, CGM Transmitter Market, CGM User and CGM Reimbursement), Companies (Abbott Laboratories, Roche, Tandem Diabetes Care, Dexcom Inc, and Senseonics)" provides a detailed analysis of Continuous Glucose Monitoring (CGM) Industry.

By Components - the market has been studied based on 2 viewpoints:

1. Glucose Sensor Market

2. CGM Transmitter Market

By Countries - the market has been studied for 11 countries:

1. United States

2. Canada

3. Germany

4. Australia

5. France

6. Netherlands

7. Switzerland

8. Sweden

9. Israel

10. United Kingdom

11. Japan

The above-mentioned countries have been studied from 7 viewpoints:

1. Diabetes Population

• Type 1
• Type 2

2. CGM Market

3. CGM Market by Components

4. Glucose Sensor Market

5. CGM Transmitter Market

6. CGM User

7. CGM Reimbursement

Company Insights:

• Overview
• Recent Development
• Revenue

Companies Covered:

1. Abbott Laboratories

2. Roche

3. Tandem Diabetes Care

4. Dexcom Inc

5. Senseonics

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

• 4.1 Growth Drivers
• 4.2 Challenges

5. Global CGM Market and User Analysis

• 5.1 Market
• 5.2 User

6. By Components - Continuous Glucose Monitoring Market

• 6.1 Glucose Sensor Market
• 6.2 CGM Transmitter Market

7. Global CGM Market and CGM User Share Analysis

• 7.1 CGM Market Share
  • 7.1.1 Glucose Sensor Market Share
  • 7.1.2 CGM Transmitter Market Share
• 7.2 CGM User Share

8. Global CGM (Continuous Glucose Monitoring) Reimbursement Model

9. Abbott Freestyle Libre vs CGM (Continuous Glucose Monitoring)

10. United States

• 10.1 Diabetes Population
  • 10.1.1 Type 1
  • 10.1.2 Type 2
• 10.2 United States - CGM Market
  • 10.2.1 United States - CGM Market by Components
    • 10.2.1.1 Glucose Sensor Market
    • 10.2.1.2 CGM Transmitter Market
• 10.3 United States - CGM User
• 10.4 CGM Reimbursement in United States

11. Canada

• 11.1 Diabetes Population
  • 11.1.1 Type 1
  • 11.1.2 Type 2
• 11.2 Canada - CGM Market
  • 11.2.1 Canada - CGM Market by Components
    • 11.2.1.1 Glucose Sensor Market
    • 11.2.1.2 CGM Transmitter Market
• 11.3 Canada - CGM User
• 11.4 CGM Reimbursement in United States

12. Germany

• 12.1 Diabetes Population
  • 12.1.1 Type 1
  • 12.1.2 Type 2
• 12.2 Germany - CGM Market
  • 12.2.1 Germany - CGM Market by Components
    • 12.2.1.1 Glucose Sensor Market
    • 12.2.1.2 CGM Transmitter Market
• 12.3 Germany - CGM User
• 12.4 CGM Reimbursement in United States

13. Australia

• 13.1 Diabetes Population
  • 13.1.1 Type 1
  • 13.1.2 Type 2
• 13.2 Australia - CGM Market
  • 13.2.1 Australia - CGM Market by Components
    • 13.2.1.1 Glucose Sensor Market
    • 13.2.1.2 CGM Transmitter Market
• 13.3 Australia - CGM User
• 13.4 CGM Reimbursement in United States

14. France

• 14.1 Diabetes Population
  • 14.1.1 Type 1
  • 14.1.2 Type 2
• 14.2 France - CGM Market
  • 14.2.1 France - CGM Market by Components
    • 14.2.1.1 Glucose Sensor Market
    • 14.2.1.2 CGM Transmitter Market
• 14.3 France - CGM User
• 14.4 CGM Reimbursement in United States

15. Netherlands

• 15.1 Diabetes Population
  • 15.1.1 Type 1
  • 15.1.2 Type 2
• 15.2 Netherlands - CGM Market
  • 15.2.1 Netherlands - CGM Market by Components
    • 15.2.1.1 Glucose Sensor Market
    • 15.2.1.2 CGM Transmitter Market
• 15.3 Netherlands - CGM User
• 15.4 CGM Reimbursement in United States

16. Switzerland

• 16.1 Diabetes Population
  • 16.1.1 Type 1
  • 16.1.2 Type 2
• 16.2 Switzerland - CGM Market
  • 16.2.1 Switzerland - CGM Market by Components
    • 16.2.1.1 Glucose Sensor Market
    • 16.2.1.2 CGM Transmitter Market
• 16.3 Switzerland - CGM User
• 16.4 CGM Reimbursement in United States

17. Sweden

• 17.1 Diabetes Population
  • 17.1.1 Type 1
  • 17.1.2 Type 2
• 17.2 Sweden - CGM Market
  • 17.2.1 Sweden - CGM Market by Components
    • 17.2.1.1 Glucose Sensor Market
    • 17.2.1.2 CGM Transmitter Market
• 17.3 Sweden - CGM User
• 17.4 CGM Reimbursement in United States

18. Israel

• 18.1 Diabetes Population
  • 18.1.1 Type 1
  • 18.1.2 Type 2
• 18.2 Israel - CGM Market
  • 18.2.1 Israel - CGM Market by Components
    • 18.2.1.1 Glucose Sensor Market
    • 18.2.1.2 CGM Transmitter Market
• 18.3 Israel - CGM User
• 18.4 CGM Reimbursement in United States

19. United Kingdom

• 19.1 Diabetes Population
  • 19.1.1 Type 1
  • 19.1.2 Type 2
• 19.2 United Kingdom - CGM Market
  • 19.2.1 United Kingdom - CGM Market by Components
    • 19.2.1.1 Glucose Sensor Market
    • 19.2.1.2 CGM Transmitter Market
• 19.3 United Kingdom - CGM User
• 19.4 CGM Reimbursement in United States

20. Japan

• 20.1 Diabetes Population
  • 20.1.1 Type 1
  • 20.1.2 Type 2
• 20.2 Japan - CGM Market
  • 20.2.1 Japan - CGM Market by Components
    • 20.2.1.1 Glucose Sensor Market
    • 20.2.1.2 CGM Transmitter Market
• 20.3 Japan - CGM User
• 20.4 CGM Reimbursement in United States

21 Company Analysis

• 21.1 Abbott Laboratories
  • 21.1.1 Overview
  • 21.1.2 Recent Development
  • 21.1.3 Revenue
• 21.2 Roche
  • 21.2.1 Overview
  • 21.2.2 Recent Development
  • 21.2.3 Revenue
• 21.3 Tandem Diabetes Care
  • 21.3.1 Overview
  • 21.3.2 Recent Development
  • 21.3.3 Revenue
• 21.4 Dexcom Inc
  • 21.4.1 Overview
  • 21.4.2 Recent Development
  • 21.4.3 Revenue
• 21.5 Senseonics
  • 21.5.1 Overview
  • 21.5.2 Recent Development
  • 21.5.3 Revenue